JP2002513418A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513418A5
JP2002513418A5 JP1999501086A JP50108699A JP2002513418A5 JP 2002513418 A5 JP2002513418 A5 JP 2002513418A5 JP 1999501086 A JP1999501086 A JP 1999501086A JP 50108699 A JP50108699 A JP 50108699A JP 2002513418 A5 JP2002513418 A5 JP 2002513418A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1999501086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513418A (ja
Filing date
Publication date
Priority claimed from GBGB9711962.2A external-priority patent/GB9711962D0/en
Application filed filed Critical
Publication of JP2002513418A publication Critical patent/JP2002513418A/ja
Publication of JP2002513418A5 publication Critical patent/JP2002513418A5/ja
Ceased legal-status Critical Current

Links

JP50108699A 1997-06-10 1998-06-08 治療活性組成物 Ceased JP2002513418A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9711962.2 1997-06-10
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions
PCT/GB1998/001673 WO1998056356A1 (en) 1997-06-10 1998-06-08 Therapeutically active compositions

Publications (2)

Publication Number Publication Date
JP2002513418A JP2002513418A (ja) 2002-05-08
JP2002513418A5 true JP2002513418A5 (https=) 2005-12-08

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50108699A Ceased JP2002513418A (ja) 1997-06-10 1998-06-08 治療活性組成物

Country Status (17)

Country Link
US (1) US6201014B1 (https=)
EP (1) EP0988028B1 (https=)
JP (1) JP2002513418A (https=)
KR (1) KR20010013618A (https=)
CN (1) CN1198594C (https=)
AR (1) AR012960A1 (https=)
AT (1) ATE262892T1 (https=)
AU (1) AU737606B2 (https=)
BR (1) BR9809994A (https=)
CA (1) CA2291796C (https=)
DE (1) DE69822822T2 (https=)
GB (3) GB9711962D0 (https=)
HU (1) HUP0004245A2 (https=)
ID (1) ID22878A (https=)
PL (1) PL337337A1 (https=)
WO (1) WO1998056356A1 (https=)
ZA (1) ZA984920B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
AU3582101A (en) * 2000-03-01 2001-09-12 Euro-Celtique S.A. The treatment of functional gastrointestinal disorders
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US7198804B2 (en) * 2002-04-12 2007-04-03 Helixir Co., Ltd. Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
AU2005309586A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
JP5775246B2 (ja) 2004-12-28 2015-09-09 メステックス アクチェンゲゼルシャフトMestex Ag 関節痛を治療する薬剤を生成するためのレシニフェラトキシン(rtx)の使用方法および前記薬剤を適用する方法
WO2008052183A2 (en) 2006-10-27 2008-05-02 Bmb Patent Holding Corporation Therapeutic compositions and methods of treatment with capsianoside-type compounds
AU2008292907A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
US8697155B2 (en) * 2008-07-22 2014-04-15 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
JP2016516717A (ja) 2013-03-15 2016-06-09 シーダーズ−サイナイ メディカル センター メタン細菌に起因または関連する疾患および状態を診断、選択、および処置する方法
JP2017509596A (ja) 2014-01-30 2017-04-06 オムニアクティブ ヘルス テクノロジーズ リミテッド 辛味がある油性芳香性物質の組成物およびその調製方法
KR102425303B1 (ko) 2014-08-13 2022-07-25 세다르스-신나이 메디칼 센터 항-메탄생성 조성물 및 그것의 용도
WO2016161085A1 (en) * 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
WO2021011002A1 (en) * 2019-07-18 2021-01-21 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
FI4135652T3 (fi) * 2020-04-15 2025-01-21 Gruenenthal Gmbh Resiniferatoksiinikoostumuksia
AU2022207425A1 (en) * 2021-01-15 2023-07-06 Dignify Therapeutics, Llc Compositions and methods for inducing defecation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) * 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
EP0015334B1 (en) * 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
DE4392300T1 (de) * 1992-05-21 1995-12-07 Jeff J Staggs Therapeutische Gebräuche von beißenden Pflanzen und Ihre Verwandten Zusammensetzungen
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP0839037B1 (en) * 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids

Similar Documents

Publication Publication Date Title
JP2000510751A5 (https=)
JP2000509942A5 (https=)
JP2000509912A5 (https=)
JP2000509637A5 (https=)
JP2002501390A5 (https=)
JP2001504744A5 (https=)
JP2002511785A5 (https=)
JP2001517324A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2002511782A5 (https=)
JP2000513896A5 (https=)
JP2002513418A5 (https=)
JP2000509804A5 (https=)
JP2001517357A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2002512647A5 (https=)
JP2000510247A5 (https=)
JP2000510969A5 (https=)
JP2000508836A5 (https=)
JP2000509818A5 (https=)
JP2001501427A5 (https=)
JP2000509520A5 (https=)
JP2002511169A5 (https=)